Acquired severe aplastic anemia in children: Is there a standard of care?
- 23 October 2004
- journal article
- editorial
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 43 (7) , 711-712
- https://doi.org/10.1002/pbc.20173
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assaysBritish Journal of Haematology, 2004
- High-dose cyclophosphamide as salvage therapy for severe aplastic anemiaExperimental Hematology, 2004
- Antithymocyte Globulin and Cyclosporine for Severe Aplastic AnemiaJAMA, 2003
- Durable Treatment-Free Remission after High-Dose Cyclophosphamide Therapy for Previously Untreated Severe Aplastic AnemiaAnnals of Internal Medicine, 2001
- Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in four centersTransplantation and Cellular Therapy, 2001
- High-dose cyclophosphamide in severe aplastic anaemia: a randomised trialThe Lancet, 2000
- Long‐term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantationBritish Journal of Haematology, 2000
- Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporineSeminars in Hematology, 2000
- Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantationBlood, 1996
- Late Clonal Complications in Severe Aplastic AnemiaLeukemia & Lymphoma, 1994